About Pharma and Healthcare Insight

The Pharma and Healthcare Insight is a monthly newsletter covering key regions across the globe, giving you systematic country-by-country coverage on the Pharma and Healthcare sector. It provides forecasts and expert analysis of the latest trends, regulatory changes, projects and investments across your region, as well as intelligence on the growth strategies of the leading companies. The Insight helps you plan your investment strategy, adjust existing strategies, plan for growth and development in your markets and Identify potential risks and opportunities for your business.

With the monthly newsletter you also get access to the online platform www.pharmaceuticalsinsight.com Complementing the Pharma and Healthcare Insight newsletter series, it is a unique resource providing you with the latest analysis on the key developments in the prescription, OTC and generic segments. Fully searchable content allows you to access the stories that are most important to your information needs and you can also explore the fully searchable 2 year archive by country, topic or keyword.

Pharma and Healthcare Insight is part of Business Monitor International (BMI)’s extensive portfolio of analysis. Established in 1984, BMI is a leading publisher of specialist business information on global emerging and frontier markets. The range of daily, weekly, monthly and quarterly services cover political risk, finance, macroeconomic performance, outlook and forecast, industry sectors and the business operating environment. BMI also publishes online directories profiling multinational companies active in emerging markets.

This wide-ranging and extensive coverage of all global emerging and frontier markets allow BMI to analyse and forecast the economic and political risk and business environment in a broad global context. BMI is independent from suppliers, consultancies and other organisations and its forecasts are completely proprietary. Subscribers and clients benefit from the fact that the information offered remains free from any vested interest.

With customers in over 160 countries, BMI has an international reputation for not only its highly respected analysis of news and events, but also for its leading forecasts that subscribers soon come to rely upon. More than half of the Global Fortune 500 companies, in addition to governments, banks and research centres around the world benefit from BMI’s mission to provide executives with authoritative analysis and forecasts to make informed global decisions.